Ensysce Biosciences, Inc. (ENSC)
1.16
+0.02
(+1.75%)
USD |
NASDAQ |
Dec 19, 16:00
1.16
0.00 (0.00%)
After-Hours: 20:00
Ensysce Biosciences EPS Diluted (Quarterly): -1.292 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
| NanoViricides, Inc. | -0.1045 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.729M |
| Revenue (Quarterly) | 0.4931M |
| Total Expenses (Quarterly) | 4.222M |
| Enterprise Value | 2.470M |
| Profit Margin (Quarterly) | -756.3% |
| Earnings Yield | -525.6% |
| Normalized Earnings Yield | -525.71 |